pI: 6.4942 |
Length (AA): 393 |
MW (Da): 44434 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_129210)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G37670 | WD-40 repeat-containing protein |
Arabidopsis thaliana | AT5G02430 | transducin/WD40 domain-containing protein |
Arabidopsis thaliana | AT3G15470 | WD40 domain-containing protein |
Arabidopsis thaliana | AT5G54200 | transducin/WD40 domain-containing protein |
Brugia malayi | Bm1_14955 | Hypothetical WD-repeats containing protein YKL121w, putative |
Candida albicans | CaO19.7235 | similar to S. pombe SPAC3H5.08c and to S. cerevisiae YKL121W |
Caenorhabditis elegans | CELE_R03E1.1 | Protein SYM-4 |
Cryptosporidium hominis | Chro.70601 | RIKEN cDNA 2610034K17 |
Cryptosporidium parvum | cgd7_5410 | WD40 protein |
Dictyostelium discoideum | DDB_G0282491 | hypothetical protein |
Drosophila melanogaster | Dmel_CG34133 | CG34133 gene product from transcript CG34133-RC |
Echinococcus granulosus | EgrG_000761600 | WD repeat protein |
Echinococcus multilocularis | EmuJ_000761600 | WD repeat protein |
Homo sapiens | ENSG00000131725 | WD repeat domain 44 |
Mus musculus | ENSMUSG00000036769 | WD repeat domain 44 |
Oryza sativa | 9267200 | Os12g0178633 |
Oryza sativa | 4337413 | Os04g0678300 |
Oryza sativa | 9269146 | Os04g0529400 |
Oryza sativa | 9270524 | Os11g0187000 |
Saccharomyces cerevisiae | YMR102C | hypothetical protein |
Schistosoma japonicum | Sjp_0216010 | expressed protein |
Schistosoma mansoni | Smp_171200 | hypothetical protein |
Schmidtea mediterranea | mk4.001347.03 | Putative wd-repeat protein |
Toxoplasma gondii | TGME49_263360 | WD domain, G-beta repeat-containing protein |
Trichomonas vaginalis | TVAG_078530 | WD repeat domain, putative |
Trichomonas vaginalis | TVAG_135970 | WD repeat domain, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
CELE_R03E1.1 | Caenorhabditis elegans | slow growth | wormbase |
TGME49_263360 | Toxoplasma gondii | Essentiality uncertain | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.